Teva Pharmaceutical Industries Limited (LON:0LER)

LON:0LER Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	29,539	26,604	19,974	9,188	8,407	6,525
Market Cap Growth	89.51%	33.19%	117.40%	9.29%	28.84%	-15.77%
Enterprise Value	39,677	37,669	32,974	23,815	25,127	23,592
Last Close Price	25.15	23.24	17.55	8.19	7.50	5.86
PE Ratio	28.20	25.40	-	-	-	21.19
PS Ratio	2.30	2.08	1.51	0.74	0.68	0.56
PB Ratio	5.02	4.52	4.37	1.44	1.18	0.79
P/FCF Ratio	34.63	31.19	33.39	13.90	9.72	37.44
P/OCF Ratio	24.11	21.71	20.05	8.56	6.37	11.07
EV/Sales Ratio	3.10	2.94	2.50	1.91	2.03	2.01
EV/EBITDA Ratio	10.49	10.23	9.31	6.99	7.63	7.25
EV/EBIT Ratio	13.49	12.83	12.24	9.52	11.37	10.38
EV/FCF Ratio	46.52	44.16	55.12	36.03	29.06	135.36
Debt / Equity Ratio	2.18	2.18	3.18	2.50	2.52	2.10
Debt / EBITDA Ratio	3.39	3.39	3.98	4.53	5.26	5.19
Debt / FCF Ratio	15.01	15.01	24.28	24.08	20.80	99.97
Net Debt / Equity Ratio	1.73	1.73	2.60	2.10	2.19	1.91
Net Debt / EBITDA Ratio	2.76	2.76	3.36	3.93	4.75	4.86
Net Debt / FCF Ratio	11.91	11.91	19.87	20.25	18.11	90.80
Asset Turnover	0.43	0.43	0.40	0.36	0.33	0.32
Inventory Turnover	2.69	2.69	2.41	2.09	2.08	2.02
Quick Ratio	0.54	0.54	0.50	0.54	0.57	0.61
Current Ratio	1.04	1.04	0.98	1.02	1.05	1.14
Return on Equity (ROE)	20.79%	20.79%	-28.30%	-7.36%	-25.19%	4.09%
Return on Assets (ROA)	6.17%	6.17%	5.09%	4.55%	3.63%	3.91%
Return on Invested Capital (ROIC)	18.07%	18.73%	14.74%	12.10%	8.85%	6.18%
Return on Capital Employed (ROCE)	14.50%	14.50%	12.70%	10.20%	8.20%	8.40%
Earnings Yield	3.55%	3.94%	-6.55%	-4.78%	-24.15%	4.72%
FCF Yield	2.89%	3.21%	3.00%	7.20%	10.29%	2.67%
Buyback Yield / Dilution	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%
Total Shareholder Return	-2.83%	-2.83%	-1.07%	-0.81%	-0.27%	-1.10%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.